| 000 | 01903 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515063831.0 | ||
| 264 | 0 | _c20070529 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1744-6872 | ||
| 024 | 7 |
_a10.1097/FPC.0b013e32803e40d7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLim, Yun-Ping | |
| 245 | 0 | 0 |
_aPregnane X receptor polymorphism affects CYP3A4 induction via a ligand-dependent interaction with steroid receptor coactivator-1. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _cMay 2007 |
||
| 300 |
_a369-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aChromatography, Affinity |
| 650 | 0 | 4 |
_aClotrimazole _xpharmacology |
| 650 | 0 | 4 | _aCytochrome P-450 CYP3A |
| 650 | 0 | 4 |
_aCytochrome P-450 Enzyme System _xmetabolism |
| 650 | 0 | 4 | _aElectrophoretic Mobility Shift Assay |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aGrowth Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHistone Acetyltransferases _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoprecipitation |
| 650 | 0 | 4 | _aLigands |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 |
_aMutation _xgenetics |
| 650 | 0 | 4 | _aNuclear Receptor Coactivator 1 |
| 650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
| 650 | 0 | 4 | _aPlasmids |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPregnane X Receptor |
| 650 | 0 | 4 |
_aReceptors, Steroid _xgenetics |
| 650 | 0 | 4 |
_aRifampin _xpharmacology |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 | _aTranscriptional Activation |
| 650 | 0 | 4 | _aTwo-Hybrid System Techniques |
| 700 | 1 | _aHuang, Jin-Ding | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 17 _gno. 5 _gp. 369-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FPC.0b013e32803e40d7 _zAvailable from publisher's website |
| 999 |
_c16980095 _d16980095 |
||